In conclusion, our meta-analysis results show that low E-cadherin expression which promotes tumor staging and lymph node metastasis in patients with NSCLC, and inhibits tumor differentiation, is closely related to poor prognosis of patients with NSCLC. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.